Motesanib
-
Catalog number2022-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_nameAMG-706
-
DescriptionCell-permeable. Motesanib, also known as AMG-706, is a multikinase inhibitor that selectively targets VEGF receptors, platelet-derived growth factor receptors (PDGFRs), and Kit receptors with IC₅₀ values of 2 nM (VEGFR1), 3 nM (VEGFR2), 6 nM (VEGFR3), 84 nM (PDGFR), and 8 nM (Kit). It also potently inhibits angiogenesis and induces regression in tumor xenografts.
-
CAS Number453562-69-1
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₂H₂₃N₅O
-
Molecular Weight373.45
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (200 mg/ml) or EtOH (40 mg/ml)
-
HandlingProtect from air and moisture
-
Tag LineA potent multikinase inhibitor selective to VEGFRs and PDGFrs
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life24 months
-
MDL NumberMFCD10567689
-
PubChem CID11667893
-
SMILESCC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C
-
InChiInChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3- 9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H, 27,28)
-
InChi KeyRAHBGWKEPAQNFF-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameMotesanib
-
Alternative nameMotesanib
-